Zhichao Fu

2.8k total citations
44 papers, 254 citations indexed

About

Zhichao Fu is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhichao Fu has authored 44 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Surgery and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhichao Fu's work include Cancer Immunotherapy and Biomarkers (10 papers), Esophageal Cancer Research and Treatment (9 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Zhichao Fu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Esophageal Cancer Research and Treatment (9 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Zhichao Fu collaborates with scholars based in China, United States and Nepal. Zhichao Fu's co-authors include Kai Zheng, Jie Han, Jiajia Zhang, Lianghu Huang, Fengmei Wang, Ming Jen Tan, Zhicheng Li, Weizhen Wu, Shunliang Yang and Yuling Wu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Frontiers in Immunology.

In The Last Decade

Zhichao Fu

41 papers receiving 251 citations

Peers

Zhichao Fu

ONCOL

PRM

SURGE

Ping Ai China

Yibo Cai China

Yuki Matsubara Japan

Yiming Zhao China

Alejandro Recio‐Boiles United States

Qiuyan Xu China

Timil Patel United States

Huarong Tang China

Keita Uchino Japan

Ping Ai China

Zhichao Fu

76 ×0.8

ONCOL

74 ×0.9

PRM

42 ×0.6

SURGE

70 ×1.1

42 ×0.9

Citations per year, relative to Zhichao Fu Zhichao Fu (= 1×) peers Ping Ai

Countries citing papers authored by Zhichao Fu

Since Specialization

Citations

This map shows the geographic impact of Zhichao Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhichao Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhichao Fu more than expected).

Fields of papers citing papers by Zhichao Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhichao Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhichao Fu. The network helps show where Zhichao Fu may publish in the future.

Co-authorship network of co-authors of Zhichao Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhichao Fu. A scholar is included among the top collaborators of Zhichao Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhichao Fu. Zhichao Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Jie, Jiaying Zhang, Yongpan Liu, et al.. (2025). Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics. BMC Cancer. 25(1). 438–438.

Wang, Jun, Ziwei Ma, Zhichao Fu, et al.. (2024). Enhanced Antioxidative Capacity Transfer between Sow and Fetus via the Gut–Placenta Axis with Dietary Selenium Yeast and Glycerol Monolaurate Supplementation during Pregnancy. Antioxidants. 13(2). 141–141. 6 indexed citations

Yang, Yunpeng, Yuanyuan Zhao, Wenfeng Fang, et al.. (2024). Abstract CT227: Anti-LAG-3 antibody LBL-007 in combination with anti-PD-1 antibody toripalimab, in patients with advanced malignant tumors: A phase Ib/II, open-label, multicenter, dose escalation/expansion study. Cancer Research. 84(7_Supplement). CT227–CT227. 1 indexed citations

Feng, Jing, et al.. (2024). Postoperative concurrent chemoradiotherapy plus apatinib for patients with high-grade glioma: a retrospective cohort study. Chinese Clinical Oncology. 13(6). 82–82.

Zheng, Xiaoyu, Xuemei Zhou, Yueqi Zhao, et al.. (2024). Plant essential oils combined with organic acids restored lipopolysaccharide-induced leaky intestine via gut microbial modulation in weaned piglets. Animal nutrition. 18. 419–432. 2 indexed citations

Guo, Li, et al.. (2024). Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB. Breast Cancer. 31(3). 426–439. 3 indexed citations

Zhang, Bao, Shenghan Wang, Zhichao Fu, et al.. (2023). Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion. Frontiers in Genetics. 13. 1073232–1073232. 8 indexed citations

Chen, Xiancheng, et al.. (2023). Prognostic nutritional index predicts the prognosis of patients with advanced esophageal cancer treated with immune checkpoint inhibitors: a retrospective cohort study. Journal of Gastrointestinal Oncology. 14(1). 54–63. 8 indexed citations

Chen, Yang, et al.. (2023). Rapid Production Biofloc by Inoculating Chlorella pyrenoidosa in a Separate Way. Water. 15(3). 536–536. 5 indexed citations

10.

Li, Guo, et al.. (2022). Real-world experience with anti–programmed cell death protein 1 immunotherapy in patients with esophageal cancer: A retrospective single-center study. Frontiers in Oncology. 12. 880053–880053. 3 indexed citations

11.

Fu, Zhichao, et al.. (2021). A Muscle-Invasive Bladder Cancer Patient With High Tumor Mutational Burden and RB1 Mutation Achieved Bladder Preservation Following Chemotherapy Combined With Immunotherapy: A Case Report. Frontiers in Immunology. 12. 684879–684879. 6 indexed citations

12.

Fu, Zhichao, et al.. (2020). Does brain radiotherapy improve survival in patients with esophageal squamous cell carcinoma with brain metastasis?. Annals of Palliative Medicine. 9(3). 637–643. 1 indexed citations

13.

Duan, Jingxian, Yuling Wu, Jikui Liu, et al.. (2019). <p>Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine</p>. Journal of Hepatocellular Carcinoma. Volume 6. 151–166. 27 indexed citations

14.

Fu, Zhichao, et al.. (2017). Prostate cancer treated with reduced-volume intensity-modulated radiation therapy. Medicine. 96(52). e9450–e9450. 3 indexed citations

15.

Lei, Yong, Zhichao Fu, Jing Feng, et al.. (2016). Long-term cancer-related fatigue outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with hormonal therapy. Medicine. 95(25). e3948–e3948. 8 indexed citations

16.

Zheng, Kai, Weizhen Wu, Shunliang Yang, et al.. (2016). Treatment of radiation-induced acute intestinal injury with bone marrow-derived mesenchymal stem cells. Experimental and Therapeutic Medicine. 11(6). 2425–2431. 11 indexed citations

17.

Zheng, Kai, Weizhen Wu, Shunliang Yang, et al.. (2015). Bone marrow mesenchymal stem cell implantation for the treatment of radioactivity-induced acute skin damage in rats. Molecular Medicine Reports. 12(5). 7065–7071. 15 indexed citations

18.

Cheng, Liping, et al.. (2014). Long-term quality of life outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with androgen deprivation. Medical Oncology. 31(6). 991–991. 6 indexed citations

19.

Fu, Zhichao, et al.. (2012). A preliminary study on the consistency between the non-surgical staging and the surgical-pathological staging in oesophageal carcinoma. Interactive Cardiovascular and Thoracic Surgery. 15(3). 344–347. 3 indexed citations

20.

Fu, Zhichao, Jianming Cai, Qi Chen, et al.. (2006). Expression Changes of ERK1/2, STAT3 and SHP-2 in Bone Marrow Cells from γ-ray Induced Leukemia Mice. Journal of Radiation Research. 47(2). 121–130. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact